Friday, Aug 19, 2022
Focus on the big picture

COVID-19: Canadian manufacturer Medicago says its vaccine shows promise in trials

CA, 08 Dec 2021
Although the data still needs to be scrutinized, Quebec company Medicago says its latest trial suggests the COVID-19 vaccine it's produced with GlaxoSmithKline is showing promise.

Their phase 3 clinical trial found the two-dose vaccine to be 71 per cent effective against most variants of COVID-19.

However, Omicron was not included as the variant wasn't known about when the trial was conducted.

Jamie Mauracher explains where the Canadian-made shot is now in the approval process and why it could help fight the pandemic beyond Canada.

For more info, please go to

Subscribe to Global News Channel HERE:
Like Global News on Facebook HERE:
Follow Global News on Twitter HERE:
Follow Global News on Instagram HERE:
#GlobalNews #Medicago #COVID-19Vaccine
Related Articles